未登录

H

Hongyu Qiu

Sichuan University

H指数:32

被引数:3,044

浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

miR-7974 as a potential biomarker for lupus nephritis and its involvement in disease progression

miR-7974作为狼疮肾炎的潜在生物标志物及其在疾病进展中的参与

IF2.4

2025-11-060

OAAI

Dual Role of Transformer 2 Beta as Both a Developmental Necessity and a Disease Modulator

Transformer 2 Beta作为发育必需因子和疾病调节因子的双重作用

International Journal of Molecular Sciences 2025, Vol. 26, Page 8805

IF0

2025-09-100

OAAI

Differential impact of spotted fever group rickettsia and anaplasmosis on tick microbial ecology: evidence from multi-species comparative microbiome analysis

斑点热群立克次体和无形体病对蜱微生物生态的差异化影响：来自多物种比较微生物组分析的证据

FRONTIERS IN MICROBIOLOGY

IF4.5

2025-05-130

OA

New insights into the pharmacological inhibition of SRF activity: Key inhibitory targets and mechanisms

VASCULAR PHARMACOLOGY

IF3.5

2024-12-010

PRE

Effect of a Group-Based Personal Assistive RObot (PARO) Robot Intervention on Cognitive Function, Autonomic Nervous System Function, and Mental Well-being in Older Adults with Mild Dementia: A Randomized Controlled Trial

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION

IF3.8

2024-11-010

PRE

Recent advances in serum response factor posttranslational modifications and their therapeutic potential in cardiovascular and neurological diseases

VASCULAR PHARMACOLOGY

IF3.5

2024-09-012

OAAI

Mechanics And Genomic Profiles Reveal Aging And Developmental Lineage Heterogeneities In Human Induced Pluripotent Stem Cell-derived Smooth Muscle Cells.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2024-05-010

PRE

Amyloid-β: A potential mediator of aging-related vascular pathologies

VASCULAR PHARMACOLOGY

IF3.5

2023-10-016

OAAI

Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors

COMMUNICATIONS BIOLOGY

IF5.1

2023-04-114

OAAI

Age and Blood Pressure Contribute to Aortic Cell and Tissue Stiffness Through Distinct Mechanisms

IF8.2

2022-08-013

OA

New Progress in the Molecular Regulations and Therapeutic Applications in Cardiac Oxidative Damage Caused by Pressure Overload

IF6.6

2022-04-293

OAAI

New Insights Into Energy Substrate Utilization and Metabolic Remodeling in Cardiac Physiological Adaption

FRONTIERS IN PHYSIOLOGY

IF3.4

2022-02-2516

OAAI

Heat Shock Protein 22 in Physiological and Pathological Hearts: Small Molecule, Large Potentials

IF5.2

2021-12-308

OAAI

Functional Inhibition of Valosin-Containing Protein Induces Cardiac Dilation and Dysfunction in a New Dominant-Negative Transgenic Mouse Model

IF5.2

2021-10-268

OAAI

Metabolic Profiling and Metabolites Fingerprints in Human Hypertension: Discovery and Potential

IF3.7

2021-10-0719

OAAI

Hsp22 Deficiency Induces Age-Dependent Cardiac Dilation and Dysfunction by Impairing Autophagy, Metabolism, and Oxidative Response

IF6.6

2021-09-298

OAAI

Ablation of Sam68 in adult mice increases thermogenesis and energy expenditure

IF4.2

2021-07-123

OA

Sam68 promotes hepatic gluconeogenesis via CRTC2

NATURE COMMUNICATIONS

IF15.7

2021-06-0719

OAAI

Spaceflight decelerates the epigenetic clock orchestrated with a global alteration in DNA methylome and transcriptome in the mouse retina

PRECISION CLINICAL MEDICINE

IF5

2021-05-1710

OAAI

The Progress of Advanced Ultrasonography in Assessing Aortic Stiffness and the Application Discrepancy between Humans and Rodents

IF3.3

2021-03-065

OAAI